Tag Archives: india

Setting Biotech Standards in India

The past decade has seen considerable growth in the Indian pharmaceutical industry. The country has emerged as a key supplier of high quality and affordable medicines not only to the developing world, but also to developed economies. The sector has recorded a compound annual growth rate (CAGR) of 13.5% over the past five years and is […]
Posted in Biotech, Global | Also tagged , , | Leave a comment

Ranbaxy Suspends Shipments, Addresses Quality and Integrity Problems

Following the U.S. ban on all imports from Ranbaxy’s Toansa, India, facility, the drug maker has voluntarily suspended all shipments of bulk drugs from its manufacturing facilities both at Toansa and Dewas, in order to reassess quality controls at the plants.
Posted in Emerging Markets, FDA, Global, Regulatory, Safety | Also tagged , , | Leave a comment

Indian Pharma's Fraudulent Job Applicants

Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
Posted in Emerging Markets, Global | Also tagged , , | Leave a comment

India's Gastrointenstinal Market to Grow by 7.7% by 2019

The gastrointestinal (GI) therapeutics market for Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD) in the Asia-Pacific (APAC) region will increase in value from $564m in 2012 to $784m by 2019 (a CAGR of 4.8%), according to a new report from GBI Research.
Posted in Emerging Markets, Global | Also tagged , , , , , , , | Leave a comment

Innovation on the Rise in India

India has a name when it comes to generic drug development. According to a recent research on patent applications carried out by Withers & Rogers, innovation by Indian pharmaceutical companies has increased over the past few years; however, the quality did not match the standard seen in Europe. The research was conducted using a software […]
Posted in Global, IP, R&D | Also tagged , | Leave a comment
  • Categories

  • Meta